The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) Administrative Core includes both Senior Leadership and central Administration, and oversees all strategic, operational, and financial aspects of the WFBCCC. The two teams work in tandem to deliver the goals of the Center, thereby meeting the mission of improving the lives of people in the multi-state Piedmont and southern Appalachian region. The Senior Leadership team establishes the vision for the WFBCCC to address the strategic priorities and operational aspects of the Center, such as Program goals, transdisciplinary and translational research needs and assessment, strategic recruitment, pilot projects, external speakers, and patient accruals to clinical trials. The Deputy Director and the Associate Directors for Basic Sciences, Population Sciences, Clinical Research, Cancer Health Equity, Shared Resources, Informatics, and Administration attend these meetings. All but one of these senior leaders is newly-appointed to these roles, in response to feedback from the External Advisory Board and the 2011 Summary Statement to expand the Senior Leadership ranks in further support of the Director. Under Dr. Pasche's leadership, the WFBCCC is stronger because of this structure, and these leaders have helped create the new initiatives described in this application and brought a fresh perspective to the WFBCCC's strategic vision. The Administrative team facilitates the implementation of the vision set by WFBCCC Senior Leadership and fosters an environment of collaboration and interaction with its membership. It consists of 13 FTEs and oversees all aspects of the Center's operations, including Shared Resource personnel and process management, informatics infrastructure support and expertise, financial leadership and management, faculty recruitment and space utilization, pilot award programs, Planning and Evaluation facilitation (internal and external advisory boards/committees and speakers), clinical research management, membership management and communication, cancer health equity and community outreach activities, and personnel support. The Administrative team is also responsible for all required CCSG reporting related to membership accomplishments (e.g. funding, publications, Shared Resource usage, and clinical trial accruals). The two groups are closely linked through frequent formal and informal meetings, allowing the WFBCCC Administrative team to be responsive to the direction set forth by the Senior Leadership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-46
Application #
10092977
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-02-01
Project End
2022-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Xiao, Jiajie; Melvin, Ryan L; Salsbury Jr, Freddie R (2018) Probing light chain mutation effects on thrombin via molecular dynamics simulations and machine learning. J Biomol Struct Dyn :1-18
Mao, Chengqiong; Zhao, Yan; Li, Fang et al. (2018) P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. J Control Release 286:289-300
Diaz-Garelli, Jose-Franck; Wells, Brian J; Yelton, Caleb et al. (2018) Biopsy Records Do Not Reduce Diagnosis Variability in Cancer Patient EHRs: Are We More Uncertain After Knowing? AMIA Jt Summits Transl Sci Proc 2017:72-80
Wang, Mingxuan; Chen, Haiqin; Ailati, Aisikaer et al. (2018) Substrate specificity and membrane topologies of the iron-containing ?3 and ?6 desaturases from Mortierella alpina. Appl Microbiol Biotechnol 102:211-223
Westcott, Marlena M; Clemens, Elene A; Holbrook, Beth C et al. (2018) The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells. Vaccine 36:1174-1182
Ruiz, Jimmy; Miller, Antonius A; Tooze, Janet A et al. (2018) Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol :
Levine, Edward A; Votanopoulos, Konstantinos I; Shen, Perry et al. (2018) A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors. J Am Coll Surg 226:434-443
Addington, Elizabeth L; Sohl, Stephanie J; Tooze, Janet A et al. (2018) Convenient and Live Movement (CALM) for women undergoing breast cancer treatment: Challenges and recommendations for internet-based yoga research. Complement Ther Med 37:77-79
Park, Sun H; Keller, Evan T; Shiozawa, Yusuke (2018) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int 102:152-162
Haas, Karen M; Johnson, Kristen L; Phipps, James P et al. (2018) CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol 200:1671-1681

Showing the most recent 10 out of 548 publications